Jack Carr | Health Professions | Best Researcher Award

Published on by Global Academic Awards

Mr. Jack Carr | Health Professions | Best Researcher Award

Coventry University | United Kingdom

Mr. Jack Carr is a dedicated researcher at the University of Northumbria, Newcastle, United Kingdom, with expertise spanning exercise physiology, cardiovascular health, cancer research, and health inequalities. His multidisciplinary work integrates biomedical science and public health, exploring how physiological and genomic factors shape disease outcomes across diverse populations. He has published in reputed journals such as PLOS One, Experimental Physiology, Progress in Cardiovascular Diseases, Heart and Mind, and Cancer Medicine. His studies address critical issues including post-COVID-19 recovery, neurophysiological measurement reliability, cultural disparities in physical activity, and ethnic genomic variations in cancer. With 4 publications, 4 citations, and an h-index of 1, Mr. Jack Carr represents a promising early-career researcher contributing to the advancement of translational and community-centered health science.

Profile: Scopus | Orcid

Featured Publications

Carr, J., Faghy, M. A., Broom, D., & Ashton, R. E. M. (2025). Investigating genomic differences by ethnicity in breast, colorectal and prostate cancers: Secondary data analysis of the Genomic Data Commons (GDC) database. Cancer Medicine.

Brownson-Smith, R., Mengarelli, A., Carr, J., Fox, K. T., Orange, S. T., Cresti, N., Saxton, J., & Temesi, J. (2025). The test-retest reliability of the H-reflex and swaymeter in women aged 30–65 years. PLOS One.

Thomas, C., Kudiersky, N., Ansdell, P., Ashton, R. E., Brown, C., Bewick, T., Carr, J., Hume, E., Spillane, P., & Pastorio, E. (2025). Submaximal 2-day cardiopulmonary exercise testing to assess exercise capacity and post-exertional symptom exacerbation in people with long COVID. Experimental Physiology.

Faghy, M. A., Carr, J., Broom, D., Mortimore, G., Sorice, V., Owen, R., Arena, R., & Ashton, R. E. M. (2025). The inclusion and consideration of cultural differences and health inequalities in physical activity behaviour in the UK: The impact of guidelines and initiatives. Progress in Cardiovascular Diseases.

Faghy, M. A., Carr, J., Broom, D. R., Owen, R., & Ashton, R. E. (2025). Cardiovascular disease in the post-COVID-19 era: A narrative review on the impact of lifestyle behaviors. Heart and Mind.

Dipen Patel | Internal Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Dipen Patel | Internal Medicine | Best Researcher Award

The Ohio State University Comprehensive Cancer Center | United States

Dr. Dipen Patel, Assistant Professor in the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center, is an accomplished clinician-researcher specializing in neuroendocrine and thyroid malignancies. His research emphasizes innovative diagnostic and therapeutic strategies, including targeting anti-apoptotic pathways, immunotherapy for anaplastic thyroid cancer, and multidisciplinary management of advanced thyroid and neuroendocrine tumors. Dr. Patel has an extensive publication record with impactful articles in Endocrine Practice, Annals of Surgical Oncology, Thyroid, and Endocrine-Related Cancer, alongside numerous abstracts and presentations at ASCO, NANETS, ENETS, and ACG, highlighting translational relevance that bridges clinical care and research. With a documented h-index of 1, three scholarly documents, and one citation, his work demonstrates growing influence in the field, establishing him as a strong candidate for the Best Researcher Award.

Profile: Scopus

Featured Publications

Patel, D., Sukrithan, V., Ahmed, U., Krause, H., Gandhi, N., Elliott, A., Hinton, A., Walker, P., Vanderwalde, A., Zhou, Y., Lou, E., Soares, H. P., Rogers, K. A., & Konda, B. (2025). Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms. Endocrine-Related Cancer, 32(7), e240341.

Pingping Cai | Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Pingping Cai | Medicine | Best Researcher Award

Professor at Shandong Provincial Hospital Affiliated to Shandong First Medical University, China

Prof. Pingping Cai is a distinguished expert in Traditional Chinese Medicine (TCM), specializing in gynecological and reproductive health. She is a Professor at the Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, China. With a Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine, her research focuses on TCM treatments for infertility, gynecological tumors, pregnancy disorders, breast diseases, and reproductive endocrine diseases. Prof. Cai has published extensively in peer-reviewed journals and actively contributes to advancing TCM-based therapies. Her expertise integrates classical TCM principles with modern biomedical approaches, making significant contributions to women’s health. She has received numerous accolades for her research and clinical excellence. 🌿🏥📚

Publication Top Notes

scopus

🎓 Education

Prof. Pingping Cai earned her Ph.D. in Gynecology of TCM from Guangzhou University of Chinese Medicine (2003-2006), where she focused on integrating classical Chinese medical theories with modern gynecological treatments. She completed her Master’s degree in Gynecology of TCM at Shandong University of Traditional Chinese Medicine (2000-2003), deepening her expertise in diagnosing and treating gynecological disorders using herbal medicine and acupuncture. Her Bachelor’s degree in Chinese Medicine from the same university (1992-1997) laid a strong foundation in TCM principles, pulse diagnosis, and herbal formulations. Throughout her academic journey, she gained extensive knowledge in reproductive endocrinology, pregnancy-related disorders, and the holistic management of female health conditions. Her education was enriched by hands-on clinical training and research in renowned hospitals, allowing her to develop innovative TCM-based approaches for treating complex gynecological diseases. Her academic excellence and research contributions have significantly shaped the integration of TCM into modern medical practice. 🎓📖🌱

💼 Experience

Since 2006, Prof. Pingping Cai has been serving as a Professor in the Department of Traditional Chinese Medicine at Shandong Provincial Hospital Affiliated to Shandong First Medical University, where she specializes in treating infertility, gynecological tumors, and pregnancy-related conditions using TCM. She plays a crucial role in integrating TCM with modern gynecology, mentoring young researchers, and advancing clinical methodologies. Before her current role, she worked at Qingdao Licang District Hospital (1997-2000) in the Department of Chinese Medicine, focusing on herbal formulations and acupuncture therapies for women’s health issues. Her clinical expertise includes managing polycystic ovary syndrome (PCOS), endometriosis, and menopause symptoms through personalized herbal prescriptions. She has contributed to numerous hospital-based research projects and collaborated with multidisciplinary teams to enhance the efficacy of TCM treatments. Her commitment to innovation and evidence-based practice has made her a leading figure in TCM gynecology. 🏥🌿👩‍⚕️

🏅 Awards & Honors

Prof. Pingping Cai has received numerous awards for her contributions to Traditional Chinese Medicine and women’s health. She has been honored with the Outstanding Researcher Award in TCM Gynecology for her groundbreaking studies on herbal treatments for infertility. She was recognized by the Chinese Society of Traditional Medicine for her advancements in integrating TCM with reproductive endocrinology. Her work on the role of TCM in treating ovarian disorders earned her the Best Clinical Innovation Award. She also received the Excellence in Academic Publishing Award for her high-impact research papers in leading medical journals. Additionally, her contributions to education and mentorship have been acknowledged with the Distinguished Educator Award. She has been invited as a keynote speaker at international TCM conferences and serves as an editorial board member for several prestigious journals. Her dedication to advancing TCM in gynecological health continues to inspire the next generation of practitioners. 🏆📜🌏

🔬 Research Focus

Prof. Pingping Cai specializes in the Traditional Chinese Medicine treatment of gynecological and reproductive disorders. Her research focuses on TCM-based therapies for infertility, exploring the effects of herbal medicine and acupuncture on reproductive health. She investigates the role of TCM in treating gynecological tumors, examining herbal formulations that regulate tumor growth and immune responses. She is also dedicated to studying TCM interventions for pregnancy complications, including miscarriage prevention and fetal development. Her work on breast diseases highlights the effectiveness of TCM in managing mastitis and hormonal imbalances. Another key area of her research is the treatment of reproductive endocrine diseases, where she explores the impact of TCM on hormonal regulation in conditions like polycystic ovary syndrome (PCOS) and premature ovarian failure. Through clinical trials and molecular research, she aims to bridge traditional practices with modern medical advancements. Her contributions significantly enhance the understanding and application of TCM in gynecology. 🌿🩺📊

 

Publication Top Notes

  • Xu Y, Li Y, Zhang J, Cai P. “Hua Yu Xiao Zheng decoction induces ectopic endometrial stromal cell senescence via inhibiting the PI3K/AKT signaling.” Tissue Cell. 2025 Apr;93:102763.

    scholar.google.com

  • Shao W, Lin Z, Xiahou Z, Zhao F, Xu J, Liu X, Cai P. “Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.” Front Immunol. 2024 Jul 29;15:1438198.

    scholar.google.com

  • Wang Y, Cai P, Qi F. “Examination and analysis of the disease evidence of ‘retention of placenta’.” China Journal of Basic Medicine in Traditional Chinese Medicine. 2024;30(10):1633-1637.

    scholar.google.com

  • Wang Z, Cai P. “Cai Pingping’s experience in treating subchorionic hematoma based on the Eight Principles of Syndrome Differentiation.” Shanghai Journal of Traditional Chinese Medicine. 2024;58(04):54-57.

    scholar.google.com

  • Yan R, He J, Xue Y, Wang Y, Dong R, Cai P. “Study on the dosage pattern of Chinese herbal enema formula for the treatment of sequelae of pelvic inflammatory diseases.” Chinese Traditional Patent Medicine. 2024;46(10):3492-3496.

    scholar.google.com

  • Su N, Cai P, Dou Z, Yin X, Xu H, He J, Li Z, Li C. “Brain nuclei and neural circuits in neuropathic pain and brain modulation mechanisms of acupuncture: a review on animal-based experimental research.” Front Neurosci. 2023 Aug 30;17:1243231.

    scholar.google.com

  • Wang Y, Qiu H, Yan R, Jing W, Li J, Cai P. “Mechanisms associated with the treatment of premature ovarian insufficiency by Zuogui Pill’s formula based on differential analysis of microRNAs and network pharmacology.” Chinese Archives of Traditional Chinese Medicine. 2023;41(04):81-86+269-273.

    scholar.google.com

  • Wang Y, Yan R, Jing W, Cai P. “Investigating the mechanisms of Bei Sha Shen-Yu Zhu in the treatment of premature ovarian failure based on network pharmacology and molecular docking technique.” Traditional Chinese Drug Research and Clinical Pharmacology. 2022;33(05):645-654.

    scholar.google.com

  • Wang Z, Qi F, Cui Y, Zhao L, Sun X, Tang W, Cai P. “An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.” Biosci Trends. 2018;12(3):220-239.

    scholar.google.com

  • Cai P, Liu X, Xu Y, Qi F, Si G. “Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.” Biosci Trends. 2017;11(6):640-650.

    scholar.google.com

 

 

 

Jiaqi Lou | Clinical medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Jiaqi Lou | Clinical medicine | Best Researcher Award

Dr. Jiaqi Lou, Ningbo No.2 Hospital, China

Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Master’s degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospital’s Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.

Publication Profile

Scopus

Orcid

Education 🎓📚

Lou Jiaqi pursued his Bachelor’s degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Master’s degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.

Experience 🏥

Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospital’s Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.

Awards & Honors 🏆🎖️

Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.

Research Focus 🔬🧬

Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.

 

Publication Top Notes

  • “A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.

    ACM Digital Library

  • “Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.

    ACM Digital Library

  • “The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.

    ACM Digital Library

  • “A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.

    ACM Digital Library

  • “A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.

    ACM Digital Library

  • “Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.

    ACM Digital Library

  • “Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.

    ACM Digital Library

  • “Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.

    ACM Digital Library

  • “Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.

    ACM Digital Library

  • “PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.

    ACM Digital Library

 

 

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de parapléjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gómez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. 🏥🧬📊

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorro’s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)  🧠📅
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation 💉📅
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations 🦠📅
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations 🚻📅
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)  🧬📅
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations 🛠️📅
  • Urodynamics of Urinary Retention in Guillain-Barré Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation 🌐📅
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations 🚽📅
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – 🤖📅
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations 📊📅